|
|
 Antiretroviral Information - August 28, 2008
| Researchers of McGill University have found an HIV test using saliva to be effective in preventing pregnant Indian mothers from passing the virus to their newborns. The OraQuick test, which was approved by the U.S. Food and Drug Administration in 2004, lets doctors know within 20 minutes if a laboring pregnant mom is HIV-infected. The early detection of infection allows doctors to immediately administer anti-retroviral drugs to HIV-exposed infants, a method proven effective in preventing infection of babies from the virus that causes AIDS | | Nearly all babies born to HIV positive mothers can be free from the deadly disease if appropriate treatment is given to a woman in her pregnancy, a new study shows. Nearly 99 percent of babies were born uninfected if recommended interventions were followed during pregnancy, University College London said in a study | | Sixteen mothers of HIV-infected children here have been infected by the deadly virus, possibly through breastfeeding. Some 41 toddlers and eight adults were infected with HIV in 2007, allegedly by health workers in the southern Osh region | | A United Nations report revealed on Thursday that it achieve progress in treating children with AIDS and preventing mother-to-child transmission of HIV. The report examines progress and challenges in four key areas - preventing HIV transmission from mothers to children (PMTCT), providing paediatric treatment, preventing infection among adolescents and young people, and protecting and supporting children affected by AIDS | | A popular anti-HIV drug, Abacavir, appears to dramatically increase the risk of heart attack, a new study says. The anti-retroviral drug is used in many anti-AIDS regimens worldwide but Danish researchers have found that it almost doubled patients' chances of heart problems. In a study published online Tuesday in The Lancet medical journal, European researchers said patients may wish to consider changing treatment programs after studying more than 33,000 patients using the drug. The lesser-used drug didanosine also increased the heart attack risk by about 50 percent | |
|
|